Join
Live feed
·
NEWSReleasevia Quantisnow
IGC Pharma Inc. logo

Ascendiant Capital Markets Raises IGC Pharma Price Target to $5.50, Citing Clinical Progress and 2026 Catalysts

ByQuantisnow·Wall Street's wire, on your screen.
IGC· IGC Pharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IGC (IGC Pharma Inc.) and more on Quantisnow.